T he control of human immunodefi ciency virus (HIV) type 1 entry, reverse transcription, integration, expression and production is operated by distinct molecular mechanisms, which have been targeted by antiretroviral therapy. Among these mechanisms, nuclear factors, such as NF-κB and 45/39kD CCAAT/enhancer-binding protein-β (C/EBPβ) isoforms, are important in regulating HIV-1 expression (Griffi n et al., 1989; Henderson et al., 1996) . In addition, several transcription factors can repress virus transcription, often by binding to specifi c sequences contained in the virus long terminal repeat (LTR) (Patarca et al., 1988; Subler et al., 1994; Ray & Srinivas, 1997; Weiden et al., 2000; Cicala et al., 2002; Hayes et al., 2002) . Recently, we have shown that the transcriptional factor OTK18 is induced by and suppresses HIV-1 infection in mononuclear cells (Carlson et al., 2004a) . OTK18 is classifi ed as a transcription factor as it contains 13 C 2 H 2 -type DNA-binding zinc-fi nger motifs (Saito et al., 1996) . C 2 H 2 zinc-fi nger motifs are capable of binding to a wide range of DNA sequences, including the HIV-1 LTR (Wu et al., 1995; Isalan et al., 2001) . We have demonstrated previously that one putative antiviral mechanism of OTK18 involves direct suppression of the LTR (Carlson et al., 2004a) . Mutational analyses revealed that the suppressive activity of OTK18 lies within aa 26-89. This region has homology to a family of zinc-fi nger proteins containing the Krüppel-associated box (KRAB) motif, a repression domain encoded by numerous transcription factors. Pengue et al. (1995) found that the KRAB domain fused to HIV-1 Tat was able to repress basal HIV-1 promoter activity in HeLa cells. This fi nding was supported further by the demonstration that a KRAB-containing tetracycline-binding protein can suppress HIV-1 replication through randomly integrated tetracycline-response elements within the HIV-1 genomic sequence (Herchenroder et al., 1999) . In addition, Reynolds et al. (2003) reported that a genetically engineered KRAB domain containing a C 2 H 2 -type zinc-fi nger protein could suppress Tat-mediated HIV-1 LTR activity, thereby making it an attractive candidate for antiretroviral therapy (Reynolds et al., 2003) . In this context, OTK18 is the fi rst KRAB-containing C 2 H 2 zinc-fi nger protein expressed endogenously in macrophages that has antiviral activity. Interestingly, OTK18 is expressed specifi cally in the cytosol of brain mononuclear phagocytes in severe HIV-1 encephalitis and may serve as a 'surrogate' marker for HIV-1-associated Abstract : It has previously been shown by our laboratory that OTK18, a human immunodefi ciency virus (HIV)-inducible zinc-fi nger protein, reduces progeny-virion production in infected human macrophages. OTK18 antiviral activity is mediated through suppression of Tat-induced HIV-1 long terminal repeat (LTR) promoter activity. Through the use of LTRscanning mutant vectors, the specifi c regions responsible for OTK18-mediated LTR suppression have been defi ned. Two different LTR regions were identifi ed as potential OTK18-binding sites by an enhanced DNA-transcription factor ELISA system; the negative-regulatory element (NRE) at -255/-238 and the Ets-binding site (EBS) at -150/-139 in the LTR. In addition, deletion of the EBS in the LTR blocked OTK18-mediated LTR suppression. These data indicate that OTK18 suppresses LTR activity through two distinct regulatory elements. Spontaneous mutations in these regions might enable HIV-1 to escape from OTK18 antiretroviral activity in human macrophages.
T he control of human immunodefi ciency virus (HIV) type 1 entry, reverse transcription, integration, expression and production is operated by distinct molecular mechanisms, which have been targeted by antiretroviral therapy. Among these mechanisms, nuclear factors, such as NF-κB and 45/39kD CCAAT/enhancer-binding protein-β (C/EBPβ) isoforms, are important in regulating HIV-1 expression (Griffi n et al., 1989; Henderson et al., 1996) . In addition, several transcription factors can repress virus transcription, often by binding to specifi c sequences contained in the virus long terminal repeat (LTR) (Patarca et al., 1988; Subler et al., 1994; Ray & Srinivas, 1997; Weiden et al., 2000; Cicala et al., 2002; Hayes et al., 2002) . Recently, we have shown that the transcriptional factor OTK18 is induced by and suppresses HIV-1 infection in mononuclear cells (Carlson et al., 2004a) . OTK18 is classifi ed as a transcription factor as it contains 13 C 2 H 2 -type DNA-binding zinc-fi nger motifs (Saito et al., 1996) . C 2 H 2 zinc-fi nger motifs are capable of binding to a wide range of DNA sequences, including the HIV-1 LTR (Wu et al., 1995; Isalan et al., 2001) . We have demonstrated previously that one putative antiviral mechanism of OTK18 involves direct suppression of the LTR (Carlson et al., 2004a) . Mutational analyses revealed that the suppressive activity of OTK18 lies within aa 26-89. This region has homology to a family of zinc-fi nger proteins containing the Krüppel-associated box (KRAB) motif, a repression domain encoded by numerous transcription factors. Pengue et al. (1995) found that the KRAB domain fused to HIV-1 Tat was able to repress basal HIV-1 promoter activity in HeLa cells. This fi nding was supported further by the demonstration that a KRAB-containing tetracycline-binding protein can suppress HIV-1 replication through randomly integrated tetracycline-response elements within the HIV-1 genomic sequence (Herchenroder et al., 1999) . In addition, Reynolds et al. (2003) reported that a genetically engineered KRAB domain containing a C 2 H 2 -type zinc-fi nger protein could suppress Tat-mediated HIV-1 LTR activity, thereby making it an attractive candidate for antiretroviral therapy (Reynolds et al., 2003) . In this context, OTK18 is the fi rst KRAB-containing C 2 H 2 zinc-fi nger protein expressed endogenously in macrophages that has antiviral activity. Interestingly, OTK18 is expressed specifi cally in the cytosol of brain mononuclear phagocytes in severe HIV-1 encephalitis and may serve as a 'surrogate' marker for HIV-1-associated dementia (Carlson et al., 2004b) . Elucidation of OTK18-binding sequences within the HIV-1 LTR is critical for the molecular characterization of OTK18 antiviral activity.
In this study, we employed all 27 LTR promoter linkerscanning mutants fused to the luciferase gene to screen for potential OTK18 response elements in the LTR (-453/+18) of the HXB2 clone (Zeichner et al., 1991) . The linker-scanning mutants consecutively replaced 18 bp of wild-type sequence with an NdeI-XhoI-SalI(NXS) polylinker (CATAT-GCTCGAGGTCGAC) across the U3 and R regions. Human embryonic kidney 293 cells (10 5 cells per well on 24-well plates; Fisher Scientifi c) were co-transfected with the LTR-scanning mutant luciferase vectors (300 ng), Tat1-72 expression vector (pSV2Tat72, 50 ng) (Subramani et al., 1981) , a Renilla luciferase reference construct (pTK-RL, 50 ng) and the OTK18 expression vector (pcDNA-OTK18, 1 μg) by using GenePorter (Gene Therapy Systems) as described previously (Carlson et al., 2004a) . Forty-eight hours after transfection, cells were collected and luciferase activity was measured by using a luminometer (Berthold Systems Inc.) using a Dual-Luciferase kit (Promega). As shown in Table 1 , we identifi ed six regions (A3, A8, A10, A12, B1 and B6, corresponding to -417/-400, -327/-310, -291/-274, -255/-238, -237/-220 and -147/-130), which were resistant to the OTK18-mediated gene suppression in the presence of Tat. These codes correspond to the original codes by Zeichner et al. (1991) .
The binding of OTK18 to each of these six regions was tested by a novel DNA-transcription factor ELISA, which is about tenfold more sensitive than conventional electromobility gel-shift analysis (EMSA). Development of such a technique was necessary, as binding of OTK18 to double-stranded oligonucleotides corresponding to the regions was too weak to be examined by conventional EMSA (data not shown). For that purpose, we generated a baculovirus expressing 6xHis-Express-tagged full-length OTK18 by in-frame insertion of the full-length OTK18 gene into the pBlueBacHis2A vector (Invitrogen) at the BamHI site. The resultant vector (pBlueBacHis2A-OTK18) was inserted into Bac-N-Blue Autographa californica multiple nucleopolyhedrovirus DNA by homologous recombination according to the manufacturer's protocol. Infection of Sf9 insect cells with the optimized titre of OTK18 baculovirus resulted in expression of recombinant OTK18 at 84 h postinfection, detected as a 75 kDa protein (data not shown). OTK18 protein was collected specifi cally from the nuclearextract fraction, which we used for subsequent experiments as control nuclear extract.
The DNA-transcription factor ELISA method was originally described by Reynolds et al. (2003) and is available commercially as the colorimetric ELISA TransAM kit (Active Motif). To enhance the sensitivity of the original protocol, we incorporated luminol-based conversion of hydrogen peroxidase activity to chemiluminescence by using SuperSignal ELISA Pico chemiluminescent substrate (Pierce) instead of conventional chromogenic development. As shown in Figure 1 , the colorimetric ELISA shows a statistically signifi cant difference between a non-specifi c oligonucleotide (control) and the HIV-1 LTR oligonucleotide A8 in the presence of OTK18-containing nuclear extract from 0.5 to 5 μg input (Figure 1a ), but the signal-to-noise (S/N) ratio is 1.31-1.41 and Z' factors are -5.64 to 0.045. In the case of our luminescence system, there is statistical signifi cance between two groups from 0.5 to 5 μg input (Figure 1b) , with an S/N ratio of 1.83-2.59 and Z′ factors of -0.88 to 0.85, which was calculated as described by Zhang et al. (1999) . As a higher S/N ratio and Z′ factor indicate suitability of the assay system, we conclude that our luminescence system is superior to the colorimetric system, and we chose 2 μg nuclear extract for the following experiment.
The OTK18-binding activity to each element and its sensitivity to cold probe ranging from 1x to 100x was tested (Figure 1c (Figure 1d ). Whilst regions A3, A8 and B1 demonstrated signifi cant binding to OTK18, none of them was outcompeted signifi cantly by cold probes in a dose-dependent manner (Figure 1d ). Only the A12 and EBS elements showed signifi cant binding to OTK18, which was outcompeted by cold probes. The B1 element showed OTK18 binding, but was not outcompeted by cold probe, and B6, which contains partial EBS sequence, had no binding activity. In addition, none of the binding was outcompeted by up to 100-fold excess of single-stranded oligonucleotides corresponding to the binding sequence, suggesting its specifi city to double-stranded DNA (data not shown). These data indicate that the A12 and EBS elements are potential specifi c OTK18-binding sites on the HIV-1 LTR.
The EBS is known to be an important response element for the cooperative interaction of Ets-1 with the upstream stimulatory factor (USF)-1 in HIV-1 enhancer activity (Sieweke et al., 1998) . As the B6 region does not cover EBS completely, we created an HXB2-derived LTR luciferase vector lacking EBS (-150/-139) (pLTRΔEBS-Luc) with a modifi ed QuikChange II site-directed mutagenesis kit (Stratagene) using oligonucleotide pairs and tested its promoter activity in the presence/absence of HIV-1 Tat and OTK18 in 293 cells (Figure 2) . Unexpectedly, pLTRΔEBS-Luc showed enhanced luciferase activity in the presence of Tat and OTK18 (second column) compared with Tat alone (fi rst column). Tat-activated luciferase activity of the original LTR-Luc, on the other hand, was suppressed significantly by OTK18 (Figure 2b ). This suggested that EBS is a critical element for the OTK18-mediated LTR suppression and that OTK18 has a dual regulatory function in the HIV-1 LTR, dependent on specifi c binding regions (see below). As the proximal promoter region between nucleosomes nuc0 and nuc1, where EBS is located, has been established as a critical regulatory region, EBS is an important site for the suppressive effect of OTK18. All of the above data indicate that EBS (-150/-139) is the primary OTK18 response element on the HIV-1 LTR.
We have shown previously that the transcriptional factor OTK18 suppresses both HIV-1 Tat-mediated LTR activation in vitro and HIV-1 replication in human monocytederived macrophages (MDMs) (Carlson et al., 2004a) . However, the response element for OTK18 suppression has not been determined. We have shown that OTK18 interacts with two distinct regions on the HIV-1 LTR, the NRE and EBS regions, by using LTR-scanning mutants and EMSA and through more defi ned subcloning/deletional analyses. Multiple regions of the NRE have been reported to downregulate HIV transcription (Garcia et al., 1987) . Specifi cally, NRE (-182/-153) contains a binding site for the nuclear factors USF (Sawadogo et al., 1988) , NFIL-6 (Tesmer et al., 1993) and human GATA-3 (Yang & Engel, 1993; Galio et al., 1999) . Furthermore, NRE (-220/-160) binds to nuclear matrix proteins and inhibits NF-κB activity (Hoover et al., 1996) . However, no proteins have been identifi ed that bind to NRE (-255/-238). Thus, OTK18, to the best of our knowledge, is the fi rst cellular protein to be shown to interact with this specifi c region of the NRE and suppress the HIV-1 LTR.
A number of mutations were reported at this region in LTRs derived from human genomic DNA of HIV-1-infected patients. Estable et al. (1996) reported LTR-proximal sequences from 42 HIV-1-infected cases ranging from stage I to IV patients (World Health Organization staging I-IV). Although they concluded that the Ets core sequence (ATCCG) was highly conserved, 25 of a total of 60 LTR sequences from the 42 cases were mutated in the Ets-1 element. The Ets core sequence was highly conserved in non-B subtypes (De Arellano et al., 2005) . We , was compared by using varying amounts of OTK18 protein extracts bound to a negative-control oligonucleotide (empty bars) or a double-stranded oligonucleotide corresponding to the A8 region of the HIV-1 LTR region (fi lled bars). Statistical analysis was performed by using one-way ANOVA to compare binding of each amount of extract with the binding of the negative-control oligonucleotide for the corresponding amount of extract (*P<0.001; §P<0.05). (c) Six regions of the HIV-1 LTR (A3-B6 and EBS) were screened for specifi c binding of the OTK18 protein. Binding was compared in the presence of lysis buffer alone (no lysate, fi lled bars), uninfected Sf9 cell lysate (uninfected lysate, shaded bars) or OTK18 baculovirus-infected lysate (OTK18 lysate, empty bars). Only the OTK18 lysate showed signifi cant binding (*P<0.001 compared with no lysate or uninfected lysate). (d) Binding was tested in the presence of no extract (-, empty bars), extract alone with no competing oligonucleotide (0x, fi lled bars), 1x excess of the corresponding LTR oligonucleotide (checked bars), 5x excess oligonucleotide (diagonally hatched bars), 20x excess oligonucleotide (horizontally hatched bars) or 100x oligonucleotide (shaded bars). Statistical analysis was performed by using one-way ANOVA to compare binding of each oligonucleotide with no competitor present to the corresponding no-extract condition (#P<0.001). Statistical analysis was also performed by using one-way ANOVA to compare binding of the competition conditions with the no-competitor condition for the same oligonucleotide ( †P<0.01; #P<0.001). NC, Negative control; RLU, relative luciferase units.
The common Ets sequence was TGCATCCGGAG (89 % in A, 73 % in B, 3 % in C and 38 % in D), followed by TACATCCGGGAG (5 % in A, 4 % in B, 77 % in C and 13 % in D). The most striking difference is the specifi c dominance of TACATCCGGGAG in subtype C, which will be worthwhile to pursue for future study (the mutation TAC in type C is at position -149, whereas the beginning of the core Ets sequence is at -147). Further investigation is required to understand whether LTRs derived from different subtypes impact their suppression by OTK18 and if such an impact is attributed to the difference in the Ets sequence.
The upregulation of LTRΔEBS by OTK18 in the presence, but not in the absence, of Tat is unexpected, but it indicates that OTK18 may have a dual role in LTR regulation. We have found previously that there are two forms of OTK18 (Carlson et al., 2004a) , which we defi ne as 75 kDa OTK18α and 65 kDa OTK18β. OTK18β lacks the KRAB-A box and may not act as a transcriptional suppressor. Thus, we believe that the dual gene regulation conferred by OTK18α and OTK18β may arise due to the presence or absence of different homology domains in these different OTK18 isoforms. Further study is necessary in order to characterize the expression of these OTK18 isoforms in MDMs and their respective roles in HIV-1 replication and LTR regulation.
